Difference between revisions of "Cancer Types"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) |
|||
(39 intermediate revisions by 4 users not shown) | |||
Line 4: | Line 4: | ||
== Common Adult Cancers == | == Common Adult Cancers == | ||
+ | #[[:Category:AML|Acute Myeloid Leukemia]] | ||
+ | #[[:Category:Kidney|Neoplasms of the Kidney]] | ||
+ | #[[:Category:Brain|Neoplasms of the Brain and CNS]] | ||
+ | |||
== Common Pediatric Cancers == | == Common Pediatric Cancers == | ||
== WHO Classification of Tumours of the Central Nervous System (2016) == | == WHO Classification of Tumours of the Central Nervous System (2016) == | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''CNS Tumors''' | ||
+ | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
Line 277: | Line 284: | ||
</div> | </div> | ||
'''Metastatic tumors''' | '''Metastatic tumors''' | ||
+ | </div> | ||
+ | </div> | ||
== WHO Classification of Pathology and Genetics of Head and Neck Tumors == | == WHO Classification of Pathology and Genetics of Head and Neck Tumors == | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Head and Neck Tumors''' | ||
+ | <div class="mw-collapsible-content"> | ||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
Line 284: | Line 296: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Malignant epithelial tumours | : Malignant epithelial tumours | ||
− | : Squamous cell carcinoma | + | : [[Squamous cell carcinoma]] |
− | : Lymphoepithelial carcinoma | + | : [[Lymphoepithelial carcinoma]] |
− | : Sinonasal undifferentiated carcinoma | + | : [[Sinonasal undifferentiated carcinoma]] |
− | : Adenocarcinoma | + | : [[Adenocarcinoma]] |
− | : Salivary gland-type carcinomas | + | : [[Salivary gland-type carcinomas]] |
− | : Neuroendocrine tumours | + | : [[Neuroendocrine tumours]] |
− | : Benign epithelial tumours | + | : [[Benign epithelial tumours]] |
− | : Schneiderian papillomas | + | : [[Schneiderian papillomas]] |
− | : Respiratory epithelial adenomatoid hamartoma | + | : [[Respiratory epithelial adenomatoid hamartoma]] |
− | : Salivary gland-type adenomas | + | : [[Salivary gland-type adenomas]] |
− | : Soft tissue tumours | + | : [[Soft tissue tumours]] |
− | : Malignant soft tissue tumours | + | : [[Malignant soft tissue tumours]] |
− | : Borderline and LMP tumours | + | : [[Borderline and LMP tumours]] |
− | : Benign soft tissue tumours | + | : [[Benign soft tissue tumours]] |
− | : Tumours of bone and cartilage | + | : [[Tumours of bone and cartilage]] |
− | : Malignant tumours | + | : [[Malignant tumours]] |
− | : Benign tumours | + | : [[Benign tumours]] |
− | : Haematolymphoid tumours | + | : [[Haematolymphoid tumours]] |
− | : Neuroectodermal tumours | + | : [[Neuroectodermal tumours]] |
− | : Germ cell tumours | + | : [[Germ cell tumours]] |
− | : Secondary tumours | + | : [[Secondary tumours]] |
</div> | </div> | ||
</div> | </div> | ||
Line 497: | Line 509: | ||
: Vagal paraganglioma | : Vagal paraganglioma | ||
: Laryngeal paraganglioma | : Laryngeal paraganglioma | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | == WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016) == | ||
+ | |||
+ | == WHO Classification of Tumors of Endocrine Organs == | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Endocrine Tumors''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Tumors of the pituitary''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :Pituitary adenomas | ||
+ | :Growth hormone producing adenoma | ||
+ | :Prolactin producing adenoma | ||
+ | :Thyrotropin producing adenoma | ||
+ | :ACTH producing adenoma | ||
+ | :Gonadotropin producing adenoma | ||
+ | :Null cell adenoma | ||
+ | :Plurihormonal adenoma | ||
+ | :Pituitary carcinoma | ||
+ | :Gangliocytoma | ||
+ | :Mesenchymal tumors | ||
+ | :Chordoma | ||
+ | :Meningioma | ||
+ | :Granular cell tumour | ||
+ | :Secondary tumors | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Tumors of the thyroid and parathyroid''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :Papillary carcinoma | ||
+ | :Follicular carcinoma | ||
+ | :Poorly differentiated carcinoma | ||
+ | :Undifferentiated (anaplastic) carcinoma | ||
+ | :Squamous cell carcinoma | ||
+ | :Mucoepidermoid carcinoma | ||
+ | :Sclerosing mucoepidermoid carcinomawith eosinophilia | ||
+ | :Mucinous carcinoma | ||
+ | :Medullary thyroid carcinoma | ||
+ | :Mixed medullary and follicular cell carcinoma | ||
+ | :Spindle cell tumour with thymus-like differentiation | ||
+ | :Carcinoma showing thymus-like differentiation | ||
+ | :Follicular adenoma | ||
+ | :Hyalinizing trabecular tumour | ||
+ | :Teratoma | ||
+ | :Primary lymphoma and plasmacytoma | ||
+ | :Ectopic thymoma | ||
+ | :Angiosarcoma | ||
+ | :Smooth muscle tumors | ||
+ | :Peripheral nerve sheath tumors | ||
+ | :Paraganglioma | ||
+ | :Solitary fibrous tumour | ||
+ | :Rosai-Dorfman disease | ||
+ | :Follicular dendritic cell tumour | ||
+ | :Langerhans cell histiocytosis | ||
+ | :Secondary tumors of the thyroid | ||
+ | :Parathyroid carcinoma | ||
+ | :Parathyroid adenoma | ||
+ | :Secondary tumors of the parathyroid | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Tumors of the adrenal gland''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :Adrenal cortical carcinoma | ||
+ | :Adrenal cortical adenoma | ||
+ | :Malignant adrenal phaeochromocytoma | ||
+ | :Benign phaeochromocytoma | ||
+ | :Composite phaeochromocytoma or paraganglioma | ||
+ | :Extra-adrenal paraganglioma | ||
+ | :Carotid body, jugulotympanic, vagal, laryngeal, aortico-pulmonary | ||
+ | :Gangliocytic, cauda equina, orbital, nasopharyngeal | ||
+ | :Extra-adrenal sympathetic paraganglioma | ||
+ | :Superior and inferior paraaortic | ||
+ | :Cervical, intrathoracic and urinary bladder | ||
+ | :Adenomatoid tumour | ||
+ | :Sex cord-stromal tumour | ||
+ | :Adrenal soft tissue and germ cell tumors | ||
+ | :Secondary tumors | ||
</div> | </div> | ||
</div> | </div> | ||
− | == | + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
+ | '''Tumors of the endocrine pancreas''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :Insulinoma | ||
+ | :Glucagonoma | ||
+ | :Somatostatinoma | ||
+ | :Gastrinoma | ||
+ | :VIPoma | ||
+ | :Serotonin secreting tumour | ||
+ | :ACTH and other ectopic hormone producing tumors | ||
+ | :Non-functioning tumors and microadenomas | ||
+ | :Mixed exocrine-endocrine carcinomas | ||
+ | :Poorly differentiated endocrine carcinoma | ||
+ | </div> | ||
+ | </div> | ||
− | == | + | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
+ | '''Inherited tumour syndromes''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :Multiple endocrine neoplasia type 2 | ||
+ | :Multiple endocrine neoplasia type 1 | ||
+ | :Hyperparathyroidism-Jaw tumour syndrome | ||
+ | :Von Hippel-Lindau syndrome (VHL) | ||
+ | :Familial paraganglioma-phaeochromocytoma syndromes caused by SDHB, SDHC and SDHD mutations | ||
+ | :Neurofibromatosis type 1 | ||
+ | :Carney complex | ||
+ | :McCune-Albright syndrome | ||
+ | :Familial non-medullary thyroid cancer | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
− | == WHO Classification of | + | == WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (2015) == |
− | == WHO Classification of | + | == WHO Classification of Tumors of Female Reproductive Organs (2014) == |
− | == WHO Classification of | + | == WHO Classification of Tumors of Soft Tissue and Bone (2013) == |
+ | == WHO Classification of Tumors of the Breast (2012) == | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Breast Tumors''' | ||
+ | <div class="mw-collapsible-content"> | ||
'''Invasive carcinoma of no special type (invasive ductal carcinoma)''' | '''Invasive carcinoma of no special type (invasive ductal carcinoma)''' | ||
− | |||
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
'''Special subtypes''' | '''Special subtypes''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Invasive lobular carcinoma | + | : [[Invasive lobular carcinoma]] |
− | : Tubular carcinoma and cribriform carcinoma | + | : [[Tubular carcinoma]] and [[cribriform carcinoma]] |
− | : Carcinoma with medullary features | + | : [[Carcinoma with medullary features]] |
− | : Metaplastic carcinoma | + | : [[Metaplastic carcinoma]] |
− | : Carcinoma with apocrine differentiation | + | : [[Carcinoma with apocrine differentiation]] |
− | : Salivary gland/skin adnexal type tumors | + | : [[Salivary gland/skin adnexal type tumors]] |
− | : Adenoid cystic carcinoma | + | : [[Adenoid cystic carcinoma]] |
− | : Mucoepidermoid carcinoma | + | : [[Mucoepidermoid carcinoma]] |
− | : Polymorphous carcinoma | + | : [[Polymorphous carcinoma]] |
− | : Mucinous carcinoma and | + | : [[Mucinous carcinoma]] and [[Carcinoma with signet-ring-cell differentiation]] |
− | + | : [[Carcinoma with neuroendocrine features]] | |
− | : Invasive papillary carcinoma | + | : [[Invasive papillary carcinoma]] |
− | : Invasive micropapillary carcinoma | + | : [[Invasive micropapillary carcinoma]] |
− | : Inflammatory carcinoma | + | : [[Inflammatory carcinoma]] |
: Bilateral breast carcinoma and non-synchronous breast carcinoma | : Bilateral breast carcinoma and non-synchronous breast carcinoma | ||
− | : Secretory carcinoma | + | : [[Secretory carcinoma]] |
− | : Oncocytic carcinoma | + | : [[Oncocytic carcinoma]] |
− | : Sebaceous carcinoma | + | : [[Sebaceous carcinoma]] |
− | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
− | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
− | : Acinic cell carcinoma | + | : [[Acinic cell carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 547: | Line 679: | ||
: Columnar cell lesions | : Columnar cell lesions | ||
: Atypical ductal hyperplasia | : Atypical ductal hyperplasia | ||
− | : Ductal carcinoma in situ | + | : [[Ductal carcinoma in situ]] |
</div> | </div> | ||
</div> | </div> | ||
Line 556: | Line 688: | ||
'''Intraductal papillary lesions''' | '''Intraductal papillary lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Intraductal papilloma | + | : [[Intraductal papilloma]] |
− | : Intraductal papillary carcinoma | + | : [[Intraductal papillary carcinoma]] |
− | : Encapsulated papillary carcinoma | + | : [[Encapsulated papillary carcinoma]] |
− | : Solid papillary carcinoma | + | : [[Solid papillary carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 566: | Line 698: | ||
'''Benign epithelial proliferations''' | '''Benign epithelial proliferations''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Adenosis, sclerosing adenosis and | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
− | + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] | |
− | : Microglandular adenosis, | + | : [[Radial scar and complex sclerosing lesion]] |
− | + | : [[Tubular adenoma]] | |
− | |||
− | : Radial scar and complex sclerosing lesion | ||
− | : Tubular adenoma | ||
: Lactating adenoma | : Lactating adenoma | ||
: Apocrine adenoma | : Apocrine adenoma | ||
Line 583: | Line 712: | ||
'''Myoepithelial and epithelial–myoepithelial lesions''' | '''Myoepithelial and epithelial–myoepithelial lesions''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
− | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
</div> | </div> | ||
</div> | </div> | ||
Line 593: | Line 722: | ||
: Nodular fasciitis | : Nodular fasciitis | ||
: Benign vascular lesions | : Benign vascular lesions | ||
− | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
− | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
− | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
: Inflammatory myofibroblastic tumour | : Inflammatory myofibroblastic tumour | ||
: Lipoma | : Lipoma | ||
: Granular cell tumour and benign peripheral | : Granular cell tumour and benign peripheral | ||
: nerve-sheath tumour | : nerve-sheath tumour | ||
− | : Angiosarcoma | + | : [[Angiosarcoma]] |
: Liposarcoma | : Liposarcoma | ||
: Rhabdomyosarcoma | : Rhabdomyosarcoma | ||
Line 611: | Line 740: | ||
'''Fibroepithelial tumors''' | '''Fibroepithelial tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Fibroadenoma | + | : [[Fibroadenoma]] |
− | : Phyllodes tumour | + | : [[Phyllodes tumour]] |
: Hamartoma | : Hamartoma | ||
</div> | </div> | ||
Line 622: | Line 751: | ||
: Nipple adenoma | : Nipple adenoma | ||
: Syringomatous tumour | : Syringomatous tumour | ||
− | : Paget disease | + | : [[Paget disease]] |
</div> | </div> | ||
</div> | </div> | ||
Line 629: | Line 758: | ||
'''Lymphoid and haematopoietic tumors''' | '''Lymphoid and haematopoietic tumors''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Diffuse large B-cell lymphoma | + | : [[Diffuse large B-cell lymphoma]] |
: Burkitt lymphoma | : Burkitt lymphoma | ||
: T-cell lymphoma | : T-cell lymphoma | ||
Line 642: | Line 771: | ||
'''Tumors of the male breast''' | '''Tumors of the male breast''' | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
− | : Gynaecomastia | + | : [[Gynaecomastia]] |
− | : Carcinoma of the male breast | + | : [[Carcinoma of the male breast]] |
</div> | </div> | ||
</div> | </div> | ||
Line 651: | Line 780: | ||
<div class="mw-collapsible-content"> | <div class="mw-collapsible-content"> | ||
: Inherited syndromes associated with an increased risk of breast cancer: Introduction | : Inherited syndromes associated with an increased risk of breast cancer: Introduction | ||
− | : BRCA1 and BRCA2 | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
− | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
: Ataxia telangiectasia syndrome | : Ataxia telangiectasia syndrome | ||
: Cowden syndrome | : Cowden syndrome | ||
: Lynch syndrome | : Lynch syndrome | ||
: Other breast cancer-predisposing genes | : Other breast cancer-predisposing genes | ||
+ | </div> | ||
+ | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 662: | Line 793: | ||
== WHO Classification of Tumours of the Digestive System (2010) == | == WHO Classification of Tumours of the Digestive System (2010) == | ||
− | == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | + | == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == |
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Hematological and Lymphoid Neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | |||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Myeloproliferative neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Chronic myelogenous leukaemia, BCR-ABL1 positive]] | ||
+ | :[[Chronic neutrophilic leukaemia]] | ||
+ | :[[Polycythaemia vera]] | ||
+ | :[[Primary myelofibrosis]] | ||
+ | :[[Essential thrombocythaemia]] | ||
+ | :[[Chronic eosinophilic leukaemia, NOS]] | ||
+ | :[[HAEM4:Mastocytosis]] | ||
+ | :[[Cutaneous mastocytosis]] | ||
+ | :[[Systemic mastocytosis]] | ||
+ | :[[Mast cell leukaemia]] | ||
+ | :[[Mast cell sarcoma]] | ||
+ | :[[Extracutaneous mastocytoma]] | ||
+ | :[[Myeloproliferative neoplasm, unclassifiable]] | ||
+ | </div> | ||
+ | </div> | ||
+ | '''[[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1]] | ||
+ | ''' | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Myelodysplastic/myeloproliferative neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Chronic myelomonocytic leukaemia]] | ||
+ | :[[Atypical chronic myeloid leukaemia, BCR-ABL1 negative]] | ||
+ | :[[Juvenile myelomonocytic leukaemia]] | ||
+ | :[[Myelodysplastic/myeloproliferative neoplasm, unclassifiable]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Myelodysplastic syndromes]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Myelodysplastic syndromes/neoplasms, overview]] | ||
+ | :[[Refractory cytopenia with unilineage dysplasia]] | ||
+ | :[[Refractory anaemia with ring sideroblasts]] | ||
+ | :[[Refractory cytopenia with multilineage dysplasia]] | ||
+ | :[[Refractory anaemia with excess blasts]] | ||
+ | :[[Myelodysplastic syndrome with isolated del(5q)]] | ||
+ | :[[Myelodysplastic syndrome, unclassifiable]] | ||
+ | :[[Childhood myelodysplastic syndrome]] | ||
+ | :[[Refractory cytopenia of childhood]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Acute myeloid leukaemia (AML) and related precursor neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[AML with recurrent genetic abnormalities]] | ||
+ | :[[AML with t(8;21)(q22;q22); RUNX1-RUNX1T1]] | ||
+ | :[[AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | ||
+ | :[[Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA]] | ||
+ | :[[AML with t(9;11)(p22;q23); MLLT3-MLL]] | ||
+ | :[[AML with t(6;9)(p23;q34); DEK-NUP214]] | ||
+ | :[[AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1]] | ||
+ | :[[AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1]] | ||
+ | :[[AML with mutated NPM1]] | ||
+ | :[[AML with mutated CEBPA]] | ||
+ | :[[AML with myelodysplasia-related changes]] | ||
+ | :[[Therapy-related myeloid neoplasms]] | ||
+ | :[[Acute myeloid leukaemia, NOS]] | ||
+ | :[[AML with minimal differentiation]] | ||
+ | :[[AML without maturation]] | ||
+ | :[[AML with maturation]] | ||
+ | :[[Acute myelomonocytic leukaemia]] | ||
+ | :[[Acute monoblastic and monocytic leukaemia]] | ||
+ | :[[Acute erythroid leukaemia]] | ||
+ | :[[Acute megakaryoblastic leukaemia]] | ||
+ | :[[Acute basophilic leukaemia]] | ||
+ | :[[Acute panmyelosis with myelofibrosis]] | ||
+ | :[[Myeloid sarcoma]] | ||
+ | :[[Myeloid proliferations related to Down syndrome]] | ||
+ | :[[Transient abnormal myelopoiesis]] | ||
+ | :[[Myeloid leukaemia associated with Down syndrome]] | ||
+ | :[[Blastic plasmacytoid dendritic cell neoplasm]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Acute leukaemias of ambiguous lineage]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Acute undifferentiated leukaemia]] | ||
+ | :[[Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1]] | ||
+ | :[[Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged]] | ||
+ | :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 | ||
+ | :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 | ||
+ | :[[Mixed phenotype acute leukaemia, NOS - rare types]] | ||
+ | :[[Other ambiguous lineage leukaemias]] | ||
+ | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Precursor lymphoid neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[B lymphoblastic leukaemia/lymphoma, NOS]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with hyperdiploidy]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH]] | ||
+ | :[[B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)]] | ||
+ | :[[T lymphoblastic leukaemia/lymphoma]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Mature B-cell neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Chronic lymphocytic leukaemia /small lymphocytic lymphoma]] | ||
+ | :[[B-cell prolymphocytic leukaemia]] | ||
+ | :[[Splenic marginal zone lymphoma]] | ||
+ | :[[Hairy cell leukaemia]] | ||
+ | :[[Splenic B-cell lymphoma/leukaemia, unclassifiable]] | ||
+ | :[[Splenic diffuse red pulp small B-cell lymphoma]] | ||
+ | :[[Hairy cell leukaemia-variant]] | ||
+ | :[[Lymphoplasmacytic lymphoma]] | ||
+ | :[[Heavy chain diseases]] | ||
+ | :[[Gamma heavy chain disease]] | ||
+ | :[[Mu heavy chain disease]] | ||
+ | :[[Alpha heavy chain disease]] | ||
+ | :[[Plasma cell neoplasms]] | ||
+ | :[[Monoclonal gammopathy of undetermined significance (MGUS)]] | ||
+ | :[[Plasma cell myeloma]] | ||
+ | :[[Solitary plasmacytoma of bone]] | ||
+ | :[[Extraosseous plasmacytoma]] | ||
+ | :[[Monoclonal immunoglobulin deposition diseases]] | ||
+ | :[[Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)]] | ||
+ | :[[Nodal marginal zone lymphoma]] | ||
+ | :[[Follicular lymphoma]] | ||
+ | :[[Primary cutaneous follicle centre lymphoma]] | ||
+ | :[[Mantle cell lymphoma]] | ||
+ | :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] | ||
+ | :[[T cell/histiocyte-rich large B-cell lymphoma]] | ||
+ | :[[Primary DLBCL of the CNS]] | ||
+ | :[[Primary cutaneous DLBCL, leg type]] | ||
+ | :[[EBV positive DLBCL of the elderly]] | ||
+ | :[[DLBCL associated with chronic inflammation]] | ||
+ | :[[Lymphomatoid granulomatosis]] | ||
+ | :[[Primary mediastinal (thymic) large B-cell lymphoma]] | ||
+ | :[[Intravascular large B-cell lymphoma]] | ||
+ | :[[ALK positive large B-cell lymphoma]] | ||
+ | :[[Plasmablastic lymphoma]] | ||
+ | :[[Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease]] | ||
+ | :[[Primary effusion lymphoma]] | ||
+ | :[[Burkitt lymphoma]] | ||
+ | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma]] | ||
+ | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Mature T- and NK-cell neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[T-cell prolymphocytic leukaemia]] | ||
+ | :[[T-cell large granular lymphocytic leukaemia]] | ||
+ | :[[Chronic lymphoproliferative disorder of NK cells]] | ||
+ | :[[Aggressive NK cell leukaemia]] | ||
+ | :[[Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood]] | ||
+ | :[[Systemic EBV+ T-cell lymphoproliferative disease of childhood]] | ||
+ | :[[Hydroa vacciniforme-like lymphoma]] | ||
+ | :[[Adult T-cell leukaemia/lymphoma]] | ||
+ | :[[Extranodal NK/T-cell lymphoma, nasal type]] | ||
+ | :[[Enteropathy-associated T-cell lymphoma]] | ||
+ | :[[Hepatosplenic T-cell lymphoma]] | ||
+ | :[[Subcutaneous panniculitis-like T-cell lymphoma]] | ||
+ | :[[Mycosis fungoides]] | ||
+ | :[[Sézary syndrome]] | ||
+ | :[[Primary cutaneous CD30 positive T-cell lymphoproliferative disorders]] | ||
+ | :[[Primary cutaneous peripheral T-cell lymphomas, rare subtypes]] | ||
+ | :[[Primary cutaneous gamma-delta T-cell lymphoma]] | ||
+ | :[[Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma]] | ||
+ | :[[Primary cutaneous CD4 positive small/medium T-cell lymphoma]] | ||
+ | :[[Peripheral T-cell lymphoma, NOS]] | ||
+ | :[[Angioimmunoblastic T-cell lymphoma]] | ||
+ | :[[Anaplastic large cell lymphoma, ALK positive]] | ||
+ | :[[Anaplastic large cell lymphoma, ALK negative]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Hodgkin lymphoma]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Nodular lymphocyte predominant Hodgkin lymphoma]] | ||
+ | :[[Classical Hodgkin lymphoma]] | ||
+ | :[[Nodular sclerosis classical Hodgkin lymphoma]] | ||
+ | :[[Mixed cellularity classical Hodgkin lymphoma]] | ||
+ | :[[Lymphocyte-rich classical Hodgkin lymphoma]] | ||
+ | :[[Lymphocyte-depleted classical Hodgkin lymphoma]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Immunodeficiency-associated lymphoproliferative disorders]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Lymphoproliferative diseases associated with primary immune disorders]] | ||
+ | :[[Lymphomas associated with HIV infection]] | ||
+ | :[[Post-transplant lymphoproliferative disorders (PTLD)]] | ||
+ | :[[Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD]] | ||
+ | :[[Polymorphic PTLD]] | ||
+ | :[[Monomorphic PTLD]] | ||
+ | :[[Classical Hodgkin lymphoma type PTLD]] | ||
+ | :[[Other iatrogenic immunodeficiency-associated lymphoproliferative disorders]] | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''[[Histiocytic and dendritic cell neoplasms]]''' | ||
+ | <div class="mw-collapsible-content"> | ||
+ | :[[Histiocytic sarcoma]] | ||
+ | :[[Tumours derived from Langerhans cells]] | ||
+ | :[[Langerhans cell histiocytosis]] | ||
+ | :[[Langerhans cell sarcoma]] | ||
+ | :[[Interdigitating dendritic cell sarcoma]] | ||
+ | :[[Follicular dendritic cell sarcoma]] | ||
+ | :[[Other rare dendritic cell tumours]] | ||
+ | :[[Disseminated juvenile xanthogranuloma]] | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
== Miscellaneous Cancer Types == | == Miscellaneous Cancer Types == | ||
+ | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | ||
+ | '''Miscellaneous Tumors''' | ||
+ | <div class="mw-collapsible-content"> | ||
: [[Acute Lymphoblastic Leukaemia (ALL)]] | : [[Acute Lymphoblastic Leukaemia (ALL)]] | ||
: [[Acute Myeloid Leukaemia (AML)]] | : [[Acute Myeloid Leukaemia (AML)]] | ||
− | ::[[Acute | + | ::[[HAEM5:Acute megakaryoblastic leukaemia]] |
: [[Adrenal cortical carcinoma]] | : [[Adrenal cortical carcinoma]] | ||
: [[Anal Cancer]] | : [[Anal Cancer]] | ||
Line 863: | Line 1,215: | ||
: [[Vaginal Cancer]] | : [[Vaginal Cancer]] | ||
: [[Vulval Cancer]] | : [[Vulval Cancer]] | ||
+ | </div> | ||
+ | </div> |
Latest revision as of 13:56, 12 December 2023
These classifications are based on WHO/IARC guidelines. See [1] for further details.
Common Adult Cancers
Common Pediatric Cancers
WHO Classification of Tumours of the Central Nervous System (2016)
Expand
CNS Tumors
WHO Classification of Pathology and Genetics of Head and Neck Tumors
Expand
Head and Neck Tumors
WHO Classification of Tumors of the Urinary System and Male Genital Organs (2016)
WHO Classification of Tumors of Endocrine Organs
Expand
Endocrine Tumors
WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (2015)
WHO Classification of Tumors of Female Reproductive Organs (2014)
WHO Classification of Tumors of Soft Tissue and Bone (2013)
WHO Classification of Tumors of the Breast (2012)
Expand
Breast Tumors
WHO Classification of Tumours of the Digestive System (2010)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008)
Miscellaneous Cancer Types
Expand
Miscellaneous Tumors